Connection

STEPHEN PFLUGFELDER to Immunosuppressive Agents

This is a "connection" page, showing publications STEPHEN PFLUGFELDER has written about Immunosuppressive Agents.
Connection Strength

1.797
  1. Suppressive effects of azithromycin on zymosan-induced production of proinflammatory mediators by human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2010 Nov; 51(11):5623-9.
    View in: PubMed
    Score: 0.242
  2. Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol. 2009 May-Jun; 54(3):321-38.
    View in: PubMed
    Score: 0.224
  3. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production. Cornea. 2008 Jan; 27(1):64-9.
    View in: PubMed
    Score: 0.205
  4. Integrating restasis into the management of dry eye. Int Ophthalmol Clin. 2006; 46(4):101-3.
    View in: PubMed
    Score: 0.178
  5. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea. 2005 Jan; 24(1):80-5.
    View in: PubMed
    Score: 0.166
  6. Antiinflammatory therapy for dry eye. Am J Ophthalmol. 2004 Feb; 137(2):337-42.
    View in: PubMed
    Score: 0.156
  7. Recombinant human tumor necrosis factor receptor Fc fusion protein (Etanercept): experience as a therapy for sight-threatening scleritis and sterile corneal ulceration. Eye Contact Lens. 2004 Jan; 30(1):2-5.
    View in: PubMed
    Score: 0.155
  8. Advances in the diagnosis and management of keratoconjunctivitis sicca. Curr Opin Ophthalmol. 1998 Aug; 9(4):50-3.
    View in: PubMed
    Score: 0.107
  9. Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%. Eye Contact Lens. 2014 Sep; 40(5):289-96.
    View in: PubMed
    Score: 0.081
  10. Atopic keratoconjunctivitis: A review. J Am Acad Dermatol. 2014 Mar; 70(3):569-75.
    View in: PubMed
    Score: 0.077
  11. Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. Mucosal Immunol. 2011 Jul; 4(4):397-408.
    View in: PubMed
    Score: 0.063
  12. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology. 2005 Oct; 112(10):1790-4.
    View in: PubMed
    Score: 0.044
  13. Mucous membrane pemphigoid in a patient with chronic lymphocytic leukemia. Cornea. 2004 Oct; 23(7):740-3.
    View in: PubMed
    Score: 0.041
  14. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea. 2000 Jul; 19(4):492-6.
    View in: PubMed
    Score: 0.030
  15. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998 Nov; 17(6):584-9.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.